BiomEdit Announces USDA Finding of No Significant Impact Letter for Non-Antibiotic Poultry Biologic, Clearing Path to Field Safety Trials

FOR IMMEDIATE RELEASE BiomEdit Announces USDA Finding of No Significant Impact Letter for Non-Antibiotic Poultry Biologic, Clearing Path to Field Safety Trials Regulatory milestone allows product to proceed to final phase of USDA conditional licensure process for necrotic enteritis prevention in broiler chickens GREENFIELD, IND. (November 13, 2025) – BiomEdit, Inc., a pioneering animal health […]

BiomEdit Awarded Nearly $2 Million from Bezos Earth Fund to Advance AI Model for Methane-Reduction Strategies in Cattle

BiomEdit Awarded Nearly $2 Million from Bezos Earth Fund to Advance AI Model for Methane‑Reduction Strategies in Cattle Partnership with Bioversity International USA and Yale University will build the Rumen Digital Twin to model and optimize climate‑smart feed and microbiome interventions GREENFIELD, IND. (Oct. 23, 2025) – In partnership with Bioversity International USA and Yale […]

BiomEdit Advances First-of-Its-Kind Engineered Bacteria Product to Final Development Phase, Secures Series B Funding and Adds Key Industry Leadership

BiomEdit Advances First-of-Its-Kind Engineered Bacteria Product to Final Development Phase, Secures Series B Funding and Adds Key Industry Leadership Poultry industry’s first engineered probiotic biologic moves into final development and regulatory stagesfor USDA conditional licensure and commercial scale-up GREENFIELD, IND. (July 16, 2025) – BiomEdit, a pioneering animal health biotechnology company, today announced a significant […]